Back to Search Start Over

Incremental prognostic value of coronary computed tomographic angiography over coronary artery calcium score for risk prediction of major adverse cardiac events in asymptomatic diabetic individuals

Authors :
Min, J.K. (James)
LaBounty, T.M. (Troy)
Gomez, M. (Millie)
Achenbach, S. (Stephan)
Al-Mallah, M. (Mouaz)
Budoff, M.J. (Matthew)
Cademartiri, F. (Filippo)
Callister, T.Q. (Tracy)
Chang, H.-J. (Hyuk-Jae)
Cheng, V.Y. (Victor)
Chinnaiyan, K. (Kavitha)
Chow, B.J.W. (Benjamin)
Cury, R.C. (Ricardo)
Delago, A. (Augustin)
Dunning, A.M. (Allison)
Feuchtner, G.M. (Gudrun)
Hadamitzky, M. (Martin)
Hausleiter, J. (Jörg)
Kaufmann, P.A. (Philipp)
Kim, Y-J. (Yong-Jin)
Leipsic, J. (Jonathon)
Lin, F.Y. (Fay)
Maffei, E. (Erica)
Raff, G.L. (Gilbert)
Shaw, L.J. (Leslee)
Villines, T.C. (Todd)
Berman, D.S. (Daniel)
Min, J.K. (James)
LaBounty, T.M. (Troy)
Gomez, M. (Millie)
Achenbach, S. (Stephan)
Al-Mallah, M. (Mouaz)
Budoff, M.J. (Matthew)
Cademartiri, F. (Filippo)
Callister, T.Q. (Tracy)
Chang, H.-J. (Hyuk-Jae)
Cheng, V.Y. (Victor)
Chinnaiyan, K. (Kavitha)
Chow, B.J.W. (Benjamin)
Cury, R.C. (Ricardo)
Delago, A. (Augustin)
Dunning, A.M. (Allison)
Feuchtner, G.M. (Gudrun)
Hadamitzky, M. (Martin)
Hausleiter, J. (Jörg)
Kaufmann, P.A. (Philipp)
Kim, Y-J. (Yong-Jin)
Leipsic, J. (Jonathon)
Lin, F.Y. (Fay)
Maffei, E. (Erica)
Raff, G.L. (Gilbert)
Shaw, L.J. (Leslee)
Villines, T.C. (Todd)
Berman, D.S. (Daniel)
Publication Year :
2014

Abstract

Background: Coronary artery disease (CAD) diagnosis by coronary computed tomographic angiography (CCTA) is useful for identification of symptomatic diabetic individuals at heightened risk for death. Whether CCTA-detected CAD enables improved risk assessment of asymptomatic diabetic individuals beyond clinical risk factors and coronary artery calcium scoring (CACS) remains unexplored. Methods: From a prospective 12-center international registry of 27,125 individuals undergoing CCTA, we identified 400 asymptomatic diabetic individuals without known CAD. Coronary stenosis by CCTA was graded as 0%, 1-49%, 50-69%, and ≥70%. CAD was judged on a per-patient, per-vessel and per-segment basis as maximal stenosis severity, number of vessels with ≥50% stenosis, and coronary segments weighted for stenosis severity (segment stenosis score), respectively. We assessed major adverse cardiovascular events (MACE) - inclusive of mortality, nonfatal myocardial infarction (MI), and late target vessel revascularization ≥90 days (REV)- and evaluated the incremental utility of CCTA for risk prediction, discrimination and reclassification.

Details

Database :
OAIster
Notes :
Atherosclerosis vol. 232 no. 2, pp. 298-304, English
Publication Type :
Electronic Resource
Accession number :
edsoai.ocn957100207
Document Type :
Electronic Resource
Full Text :
https://doi.org/10.1016.j.atherosclerosis.2013.09.025